MedPath

A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)

Not Applicable
Completed
Conditions
Autosomal Dominant Polycystic Kidney Disease
Interventions
Other: ADPKD Diet
Registration Number
NCT01810614
Lead Sponsor
University of Kansas
Brief Summary

Recent evidence has shown that kidney volume predicts the likelihood of developing renal insufficiency over a finite length of time in ADPKD, suggesting a linkage between the growth of cysts and the harm they do to kidney function. Recent studies indicate that the rate of kidney volume increase is hastened by excess dietary protein, salt, and potential net acid precursors, and slowed by increased water intake sufficient to lower plasma vasopressin levels.

Diets are commonly prescribed to treat ADPKD and other renal patients with disease near the end-stage, but there is currently no specific diet prescription that takes potentially harmful dietary elements into account for ADPKD patients in the earliest stages of the disease. This study will examine a novel diet for ADPKD created by the researcher termed the ADPKD diet.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Have not been prescribed dietary restrictions or enhancements
  • Blood pressure <135/85 mmHg with or without specific treatment
  • Willingness to participate for at least one month
  • Diet history consistent with the excretion of >30 mEq NAE / day based on usual dietary intake
Exclusion Criteria
  • Other active diseases requiring pharmacologic agents
  • Unstable weight (+/- 2 kg) for 3 months prior to enrollment
  • Food allergies
  • Pregnancy or lactating
  • Confounding medications, i.e. bicarbonate, citrate
  • Individuals who do not consume meat for personal, religious, or health reasons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ADPKD DietADPKD DietAll study participants will follow their regular diet for 8 days. After that, they will be asked to follow the ADPKD diet for a total of 4 weeks.
Primary Outcome Measures
NameTimeMethod
ADPKD diet impact on net acid excretionChange from Baseline to Day 36

The difference in net acid excretion from a participants regular diet and the ADPKD diet

Secondary Outcome Measures
NameTimeMethod
Acceptance of ADPKD diet36 days

Ease with which diet will be embraced by participants

Kidney injury markersChange from Baseline to Day 36

Change in urine markers of renal injury in participants

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath